Page last updated: 2024-08-16

phenylmethylsulfonyl fluoride and arachidonyl-2-chloroethylamide

phenylmethylsulfonyl fluoride has been researched along with arachidonyl-2-chloroethylamide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breitenbucher, JG; Seierstad, M1
Cioczek-Czuczwar, A; Czuczwar, P; Czuczwar, SJ; Luszczki, JJ1
Andres-Mach, M; Cioczek-Czuczwar, A; Czuczwar, P; Czuczwar, SJ; Dudra-Jastrzebska, M; Luszczki, JJ1
Andres-Mach, M; Barcicka-Klosowska, B; Florek-Luszczki, M; Haratym-Maj, A; Luszczki, JJ; Zolkowska, D1
Andres-Mach, M; Chmielewski, J; Florek-Luszczki, M; Kondrat-Wrobel, MW; Luszczki, JJ; Patrzylas, P; Szpringer, M; Zagaja, M; Zaluska, K1

Reviews

1 review(s) available for phenylmethylsulfonyl fluoride and arachidonyl-2-chloroethylamide

ArticleYear
Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
    Journal of medicinal chemistry, 2008, Dec-11, Volume: 51, Issue:23

    Topics: Amidohydrolases; Animals; Drug Discovery; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship

2008

Other Studies

4 other study(ies) available for phenylmethylsulfonyl fluoride and arachidonyl-2-chloroethylamide

ArticleYear
Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
    European journal of pharmacology, 2006, Oct-10, Volume: 547, Issue:1-3

    Topics: Amidohydrolases; Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Electroshock; Enzyme Inhibitors; Forelimb; Male; Memory; Mice; Molecular Structure; Muscles; Phenylmethylsulfonyl Fluoride; Receptor, Cannabinoid, CB1; Seizures; Time Factors; Valproic Acid

2006
Effect of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
    Progress in neuro-psychopharmacology & biological psychiatry, 2010, Feb-01, Volume: 34, Issue:1

    Topics: Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Disease Models, Animal; Drug Combinations; Electroshock; Enzyme Inhibitors; Male; Memory Disorders; Mice; Muscle Strength; Muscle, Skeletal; Phenylmethylsulfonyl Fluoride; Psychomotor Performance; Receptor, Cannabinoid, CB1; Seizures

2010
Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
    Progress in neuro-psychopharmacology & biological psychiatry, 2012, Dec-03, Volume: 39, Issue:2

    Topics: Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hand Strength; Male; Mice; Motor Activity; Pentylenetetrazole; Phenylmethylsulfonyl Fluoride; Seizures

2012
Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice.
    PloS one, 2017, Volume: 12, Issue:8

    Topics: Acetamides; Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Benzodiazepines; Clobazam; Cornea; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy, Complex Partial; Lacosamide; Levetiracetam; Male; Mice; Muscle Strength; Nipecotic Acids; Phenobarbital; Phenylmethylsulfonyl Fluoride; Piracetam; Psychomotor Performance; Receptor, Cannabinoid, CB1; Tiagabine; Valproic Acid

2017